bg
A

Akebia Therapeutics (AKBA)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Akebia Therapeutics (AKBA)

Akebia Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on producing medicines for people living with kidney disease. Its lead product candidate, vadadustat, is an oral therapy in development for the treatment of anemia due t... Read more

  • USD1.13
  • USD1.18
  • USD1.12
  • USD2.48
  • -18.60%
  • 187M
  • 2.39M
  • 3.03M
  • 254M
  • 0.78
  • 8.60%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.